Clinical observation of atypical thyroid gland carcinoma
Abstract
Clinical observation of atypical thyroid gland carcinoma
References
1. Kazaure HS, Roman SA, Sosa JA. Medullary Thyroid microcarcinoma. Cancer. 2012; 118(3): 620–7.
2. Machens A, Lorenz K, Dralle H. Utility of Serum Procalcitonin
for Screening and Risk Stratification of Medullary Thyroid Cancer. J Clin Endocrinol Metab. 2014;99(8):2986–94.
3. Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF et al. Revised American Thyroid Association Guidelines for the management of Medullary Thyroid Carcinoma Thyroid. 2015;25(6):567–610.
4. Trimboli P, Giovanella L. Serum Calcitonin Negative Medullary Thyroid Carcinoma: A Systematic Review of the Literature. Clin Chem Lab Med. 2015;53(10):1507–14.
5. Panagiotakou A, Ioannidis D, Lilis D, Karageorgos G. “Atypical” non–secretory medullary thyroid carcinoma: case report and review of the literature. Endocrinol Metab Int J. 2017;4(3):00085.
2. Machens A, Lorenz K, Dralle H. Utility of Serum Procalcitonin
for Screening and Risk Stratification of Medullary Thyroid Cancer. J Clin Endocrinol Metab. 2014;99(8):2986–94.
3. Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF et al. Revised American Thyroid Association Guidelines for the management of Medullary Thyroid Carcinoma Thyroid. 2015;25(6):567–610.
4. Trimboli P, Giovanella L. Serum Calcitonin Negative Medullary Thyroid Carcinoma: A Systematic Review of the Literature. Clin Chem Lab Med. 2015;53(10):1507–14.
5. Panagiotakou A, Ioannidis D, Lilis D, Karageorgos G. “Atypical” non–secretory medullary thyroid carcinoma: case report and review of the literature. Endocrinol Metab Int J. 2017;4(3):00085.
Published
2018-04-04
Section
Brief Communications
Copyright (c) 2018 TOV "Liga-inform"
This work is licensed under a Creative Commons Attribution 4.0 International License.